J9039 Injection, blinatumomab, 1 microgram

Billable / valid for submission HCPCS Release 2026Q3

Short description: Injection, blinatumomab

Version history

Related codes in J90

• J9000 Injection, doxorubicin hydrochloride, 10 mg
• J9003 Leuprolide injectable (camcevi etm), 1 mg
• J9011 Injection, datopotamab deruxtecan-dlnk, 1 mg
• J9015 Injection, aldesleukin, per single use vial
• J9017 Injection, arsenic trioxide, 1 mg
• J9021 Injection, asparaginase, recombinant, (rylaze), 0.1 mg
• J9022 Injection, atezolizumab, 10 mg
• J9023 Injection, avelumab, 10 mg
• J9024 Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
• J9025 Injection, azacitidine, 1 mg
• J9026 Injection, tarlatamab-dlle, 1 mg
• J9027 Injection, clofarabine, 1 mg
• J9028 Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
• J9029 Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
• J9030 Bcg live intravesical instillation, 1 mg
• J9032 Injection, belinostat, 10 mg
• J9033 Injection, bendamustine hydrochloride, 1 mg
• J9034 Injection, bendamustine hcl (bendeka), 1 mg
• J9035 Injection, bevacizumab, 10 mg
• J9036 Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg

All J90 codes →